Pelvic Inflammatory Disease - Diagnosis And Treatment In The Emergency Department, evidence-based CME
Enlarge Image
Delivery Method:

Pelvic Inflammatory Disease: Diagnosis and Treatment in the Emergency Department (Pharmacology CME) - $49.00

Publication Date: December 2016 (Volume 18, Number 12)

CME Credits: 4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits. CME expires 12/1/2019

Specialty CME Credits:: Included as part of the 4 credits, this CME activity is eligible for 2 Pharmacology CME credits, subject to your state and institutional approval.


Charles Walter Bugg, MD, PhD
Postgraduate Physician, LAC + USC Department of Emergency Medicine, Los Angeles, CA

Taku Taira, MD
Assistant Professor, Associate Program Director, LAC + USC Department of Emergency Medicine, Los Angeles, CA

Peer Reviewers

Yvette Calderon, MD, MS
Professor of Clinical Emergency Medicine, Department of Emergency Medicine; Assistant Professor, Department of Pediatrics, Albert Einstein College of Medicine; Chief of Emergency Services, North Central Bronx Hospital, Bronx, NY

Nadia Maria Shaukat, MD, RDMS, FACEP
Associate Director of Emergency Ultrasound, Department of Emergency Medicine, Weill Cornell Medical College, New York-Presbyterian Queens; Flushing, NY

Pelvic inflammatory disease is a common disease that is associated with significant complications including infertility, chronic pelvic pain, ruptured tubo-ovarian abscess, and ectopic pregnancy. The diagnosis may be delayed when the presentation has nonspecific signs and symptoms. Even when it is properly identified, pelvic inflammatory disease is often treated suboptimally. This review provides evidence-based recommendations for the diagnosis, treatment, disposition, and follow-up of patients with pelvic inflammatory disease. Arranging follow-up of patients within 48 to 72 hours and providing clear patient education are fundamental to ensuring good patient outcomes. Emerging issues, including new pathogens and evolving resistance patterns among pelvic inflammatory disease pathogens are reviewed.

Excerpt From This Issue

You arrive for your shift in the ED. The final patient you are signed out is a 30-year-old woman with lower abdominal pain whose ultrasound results are pending to rule out torsion versus ovarian cyst. You nod dutifully and go about seeing new patients. An hour into the shift, the clerk hands you the ultrasound results with the radiologist’s impression: “No radiological etiology of patient’s abdominal pain is found.” You review the chart and confirm that there is no concern for any nongynecological etiologies for her pain. The previous physician documented mild left adnexal tenderness without cervical motion tenderness or adnexal masses. Labs are notable for a urinalysis that is small leukocyte esterase positive and nitrite negative, and a wet mount without clue cells, yeast, or Trichomonas vaginalis. You confirm the documented history with the patient, who additionally denies any urinary complaints or flank pain. On your physical examination, you note only mild left lower abdominal tenderness. As the patient asks, “Why am I having this pain? Can I just go home?” you wonder if there is something else you should do.


Product Reviews
Sabrina Obrien, MD - 08/10/2017
This article was informative and concise. I will be more diligent in treating for PID when the patient has lower abdominal pain and another etiology has been ruled out.
William White, MD - 07/06/2017
As a result of this course, I will have greater sensitivity as to when to diagnose and treat PID, and I will change my initial treatment regimen to follow current CDC guidelines.
Peter Benson, MD - 07/06/2017
This was a great review of a bread and butter topic.
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.